MedicarePartD.guide

A non-government resource built from CMS public data

Repatha on Blue Medicare Rx Standard (S5540-002)

evolocumab

Covered, with prior authorization required.

Tier 3 (preferred brand). Quantity limit of 6 per 28 days.

$347.46
Patient pays / month, after deductible
$839.46
Patient pays / month, before the $615.00 deductible
$1,042.38
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

REPATHA 140 mg/mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $1,737.30 for a month. Other covered strengths are listed below.

Prior authRequired on all 2 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 2 covered strengths and forms
FormTierPatient pays / monthLimits
REPATHA 140 mg/mL Injection, Solution3$351.67PA · 6 per 28 days
REPATHA 140 mg/mL Injection, Solution3$347.46PA · 6 per 28 days

Other Non-statin cholesterol drugs on this plan

Verify with the plan before prescribing or filling. Member services: (888)247-4142. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5540-002